In a study published in Eating and Weight Disorders, researchers examined how baseline autonomous motivation and self-compassion relate to changes in eating disorder symptoms among women with anorexia nervosa receiving inpatient treatment. The investigation focused on whether these psychological factors, individually or in interaction, were associated with the magnitude of symptom reduction from admission to discharge. The findings indicated that higher levels of autonomous motivation at the start of treatment were associated with greater improvements in eating disorder pathology, whereas baseline self-compassion did not show a significant association with symptom change.
The research was conducted at Hollywood Hospital in Western Australia, where participants were recruited from an inpatient eating disorder programme between June 2016 and November 2019. The study included 56 women diagnosed with anorexia nervosa, with a mean age of 23.8 years and a range of 16 to 52 years. The sample comprised 82% of participants with the restricting subtype and 18% with the binge/purge subtype. Given the small number of participants in the binge/purge subgroup, analyses were performed on the combined sample rather than by subtype. The mean duration of inpatient treatment was 27 days, ranging from 6 to 56 days, and the mean body mass index at admission was 17.9.
The theoretical framework for the study was Self-Determination Theory, which posits that motivation exists on a continuum from amotivation to controlled motivation, and finally to autonomous motivation. Autonomous motivation is characterized by actions guided by personal values, commitment, or enjoyment, rather than external pressures such as guilt or shame. Previous research has linked higher autonomous motivation to better treatment outcomes and lower symptom severity in eating disorder populations. Self-compassion, defined as relating to oneself with kindness and non-judgement during difficulty, was examined as a potential factor that might support autonomous motivation or directly influence symptom change.
Researchers measured eating disorder symptoms using the Eating Disorder Examination-Questionnaire (EDE-Q), a 28-item self-report instrument that evaluates behavioural and psychological features of eating disorders over the past 28 days. Autonomous motivation was assessed using the Autonomous and Controlled Motivation for Treatment Questionnaire (ACMTQ), specifically the autonomous motivation subscale. Self-compassion was measured using the Self-Compassion Scale-Short Form (SCS-SF). All three measures were administered at pre-treatment and post-treatment (at point of discharge). The EDE-Q overall global score was used as a continuous measure of symptom severity, with higher scores indicating greater severity.
The statistical analysis employed latent change score (LCS) models to examine the amount of change in eating disorder symptoms over time. This approach constructs the change as a latent variable, allowing it to be treated as an outcome predicted by baseline variables. The models controlled for baseline eating disorder symptoms, body mass index, age, and treatment duration. The primary predictors were baseline autonomous motivation, baseline self-compassion, and their interaction. Bias-corrected bootstrapped confidence intervals were calculated using 10,000 bootstrap samples to account for the small sample size. Post hoc Monte Carlo simulations were conducted to assess whether the models were adequately powered to detect effects of the observed magnitude.
The results showed that higher baseline autonomous motivation was the only significant direct predictor of the amount of change in eating disorder symptoms across inpatient treatment. Specifically, each one-point increase in baseline autonomous motivation was associated with approximately a 0.3-point greater reduction in eating disorder symptoms from pre- to post-treatment. This finding supports the hypothesis that individuals who enter treatment with stronger autonomous motivation may experience greater short-term improvements in symptoms. The association was consistent with previous research indicating that autonomous motivation is linked to better treatment engagement and outcomes in eating disorder populations.
In contrast, baseline self-compassion was not significantly associated with changes in eating disorder symptoms over time. While self-compassion was negatively correlated with eating disorder symptoms at admission, it did not predict the magnitude of symptom reduction during treatment. The interaction between autonomous motivation and self-compassion was also not significant, indicating that self-compassion did not moderate the relationship between autonomous motivation and symptom change. Confidence intervals for the association between self-compassion and symptom change crossed zero across all levels of autonomous motivation, providing no evidence of a moderating effect.
The models explained approximately 49% of the variance in the change in eating disorder symptoms across time. Each one-point increase in baseline symptoms was associated with approximately a 0.4-point greater decrease across treatment. This suggests that the starting level of symptom severity plays a role in the trajectory of improvement, independent of motivational factors.
The authors noted that the findings are consistent with Self-Determination Theory, suggesting that autonomous motivation is a relevant construct in eating disorder populations. However, they emphasized that the study design was observational and did not establish causality. The findings do not demonstrate that increasing autonomous motivation will directly improve outcomes; rather, they indicate that autonomous motivation may be a useful marker of likely treatment response. The lack of association with self-compassion suggests that once autonomous motivation is considered, self-compassion may not provide additional explanatory power for symptom change in this context.
Limitations of the study include the relatively small sample size, which may have reduced the ability to detect smaller effects, particularly the hypothesized interaction between autonomous motivation and self-compassion. Only approximately 19% of admitted patients consented to participate, raising the possibility of selection bias, as those who participated may have been more motivated to engage in treatment. The inclusion of only female participants and the imbalance in anorexia nervosa subtypes constrain the generalizability of the findings. Additionally, the absence of post-discharge follow-up data limits conclusions regarding the durability of observed symptom reductions, restricting interpretation to short-term changes during inpatient treatment.
The structured nature of inpatient treatment may have reduced variability in motivation and symptom change, potentially attenuating observed associations. Motivation may also be influenced by unmeasured factors, such as perceived autonomy support and interpersonal relationships within treatment, which were not assessed in this study. The authors suggest that future research should examine whether interventions targeting autonomous motivation, such as autonomy-supportive communication approaches, are associated with improved treatment outcomes. They also recommend larger, well-powered studies with standardised outcome measures and longer-term follow-up to clarify the dynamic relationships between self-compassion, autonomous motivation, and eating disorder outcomes.
Despite these limitations, the study provides valuable insights into the psychological characteristics of individuals with anorexia nervosa who may experience greater reductions in symptoms during inpatient treatment. The findings highlight the potential utility of assessing motivation at admission to tailor intervention strategies to individual needs. By identifying autonomous motivation as a factor associated with better symptom reduction, the research underscores the importance of understanding motivational processes in eating disorder treatment. Future investigations into how to enhance autonomous motivation in patients with lower baseline levels could contribute to the development of more personalised and effective treatment approaches.
Subject of Research: Associations between baseline autonomous motivation, self-compassion, and eating disorder symptom change in anorexia nervosa inpatient treatment
Article Title: The roles of autonomous motivation and self-compassion on changes in eating disorder pathology across inpatient eating disorder treatment
Article References: Batchelor, R., Morgan-Lowes, K., Egan, S. J., Howell, J., & Thøgersen-Ntoumani, C. (2026). The roles of autonomous motivation and self-compassion on changes in eating disorder pathology across inpatient eating disorder treatment. Eating and Weight Disorders – Studies on Anorexia, Bulimia and Obesity, 31(1), Article 87. https://doi.org/10.1007/s40519-026-01890-0
Image Credits: AI Generated
DOI: 10.1007/s40519-026-01890-0
Keywords: anorexia nervosa, autonomous motivation, self-compassion, inpatient treatment, eating disorder symptoms, Self-Determination Theory, latent change score models, psychological factors, roles, autonomous, motivation, changes
News Source: Glenn Wilkins. (November 8, 2026). Autonomous Motivation Linked to Eating Disorder Symptom Reduction. Scienmag.



